Amity Island
Well-Known Member
- Relationship to Diabetes
- Type 1
The US Food and Drug Administration (FDA) has granted approval for Eli Lilly and Company’s Mounjaro (tirzepatide) injection as an adjunct to diet and exercise to enhance glycemic control in adult patients with type 2 diabetes.
Lilly’s Mounjaro receives FDA approval for type 2 diabetes treatment
The US FDA has approved Lilly's Mounjaro as an adjunct to diet and exercise to enhance glycemic control in adults with type 2 diabetes.
www.pharmaceutical-technology.com